Company:  TRANSMEDICS GROUP, INC. (TMDX)
Form Type:  4
Filing Date:  8/13/2019 
CIK:  0001756262 
Address:  200 MINUTEMAN ROAD 
City, State, Zip:  ANDOVER, Massachusetts 01810 
Telephone:  978-552-0900 
Fiscal Year:  12/28 
Last Trade
Last Trade: 
$17.81  
Change: 
0.06 (0.34%)  
Trade Time: 
Oct 15  
Market Cap: 
$376.13M
Trade TMDX now with 

© 2019  
Description of Business
We are a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. We developed the OCS to replace a decades-old standard of care that we believe is significantly limiting access to life-saving transplant therapy for hundreds of thousands of patients worldwide. Our innovative OCS technology replicates many aspects of the organ's natural living and functioning environment outside of the human body. As such, the OCS represents a paradigm shift that transforms organ preservation for transplantation from a static state to a dynamic environment that enables new capabilities, including organ optimization and assessment. We believe our substantial body of clinical evidence has demonstrated the potential for the OCS to significantly increase the number of organ transplants and improve post-transplant outcomes.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES